A phase II trial of gemcitabine and erlotinib followed by ChemoProton therapy plus capecitabine and oxaliplatin for locally advanced pancreatic cancer

Samrat M. Sanghvi; Alex R. Coffman; Chung Tsen Hsueh; Joseph Kang; Annie Park; Naveenraj L. Solomon; Carlos A. Garberoglio; Mark E. Reeves; Jerry D. Slater; Gary Y. Yang

doi:10.21037/jgo-22-327

A phase II trial of gemcitabine and erlotinib followed by ChemoProton therapy plus capecitabine and oxaliplatin for locally advanced pancreatic cancer

Samrat M. Sanghvi, Alex R. Coffman, Chung Tsen Hsueh, Joseph Kang, Annie Park, Naveenraj L. Solomon, Carlos A. Garberoglio, Mark E. Reeves, Jerry D. Slater, Gary Y. Yang

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1989-1996
Number of pages	8
Journal	Journal of Gastrointestinal Oncology
Volume	13
Issue number	4
DOIs	https://doi.org/10.21037/jgo-22-327
State	Published - Aug 2022

ASJC Scopus Subject Areas

Oncology
Gastroenterology

Keywords

Locally advanced pancreatic cancer (LAPC)
chemotherapy
erlotinib
proton radiation therapy
targeted therapy

Access to Document

10.21037/jgo-22-327

OpenUrl availability

Full text

Cite this

Sanghvi, S. M., Coffman, A. R., Hsueh, C. T., Kang, J., Park, A., Solomon, N. L., Garberoglio, C. A., Reeves, M. E., Slater, J. D., & Yang, G. Y. (2022). A phase II trial of gemcitabine and erlotinib followed by ChemoProton therapy plus capecitabine and oxaliplatin for locally advanced pancreatic cancer. Journal of Gastrointestinal Oncology, 13(4), 1989-1996. https://doi.org/10.21037/jgo-22-327

Sanghvi, SM, Coffman, AR, Hsueh, CT, Kang, J, Park, A, Solomon, NL , Garberoglio, CA , Reeves, ME, Slater, JD & Yang, GY 2022, 'A phase II trial of gemcitabine and erlotinib followed by ChemoProton therapy plus capecitabine and oxaliplatin for locally advanced pancreatic cancer', Journal of Gastrointestinal Oncology, vol. 13, no. 4, pp. 1989-1996. https://doi.org/10.21037/jgo-22-327

@article{f73682cf724d4c1ab32608ef1901918f,

title = "A phase II trial of gemcitabine and erlotinib followed by ChemoProton therapy plus capecitabine and oxaliplatin for locally advanced pancreatic cancer",

keywords = "Locally advanced pancreatic cancer (LAPC), chemotherapy, erlotinib, proton radiation therapy, targeted therapy",

author = "Sanghvi, {Samrat M.} and Coffman, {Alex R.} and Hsueh, {Chung Tsen} and Joseph Kang and Annie Park and Solomon, {Naveenraj L.} and Garberoglio, {Carlos A.} and Reeves, {Mark E.} and Slater, {Jerry D.} and Yang, {Gary Y.}",

year = "2022",

month = aug,

doi = "10.21037/jgo-22-327",

language = "English",

volume = "13",

pages = "1989--1996",

journal = "Journal of Gastrointestinal Oncology",

issn = "2078-6891",

number = "4",

}

TY - JOUR

T1 - A phase II trial of gemcitabine and erlotinib followed by ChemoProton therapy plus capecitabine and oxaliplatin for locally advanced pancreatic cancer

AU - Sanghvi, Samrat M.

AU - Coffman, Alex R.

AU - Hsueh, Chung Tsen

AU - Kang, Joseph

AU - Park, Annie

AU - Solomon, Naveenraj L.

AU - Garberoglio, Carlos A.

AU - Reeves, Mark E.

AU - Slater, Jerry D.

AU - Yang, Gary Y.

PY - 2022/8

Y1 - 2022/8

KW - Locally advanced pancreatic cancer (LAPC)

KW - chemotherapy

KW - erlotinib

KW - proton radiation therapy

KW - targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=85137931800&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85137931800&partnerID=8YFLogxK

U2 - 10.21037/jgo-22-327

DO - 10.21037/jgo-22-327

M3 - Article

C2 - 36092320

AN - SCOPUS:85137931800

SN - 2078-6891

VL - 13

SP - 1989

EP - 1996

JO - Journal of Gastrointestinal Oncology

JF - Journal of Gastrointestinal Oncology

IS - 4

ER -

A phase II trial of gemcitabine and erlotinib followed by ChemoProton therapy plus capecitabine and oxaliplatin for locally advanced pancreatic cancer

ASJC Scopus Subject Areas

Keywords

Access to Document

OpenUrl availability

Other files and links

Cite this